Dexmedetomidine is a potent a 2 adrenergic agonist, with sedative and analgesic properties which may make it a suitable sedative agent for procedures on paediatric patients. A six-year-old boy required sedation for stereotactic radiosurgical ablation of an arteriovenous malformation on two occasions. Sedation with dexmedetomidine was planned, with increased dosage used on the second occasion. On both occasions dexmedetomidine was inadequate as a sole agent and required supplementation with other agents.
The treatment of intracranial arteriovenous malformations (AVMs) in younger children with stereotactic radiosurgery presents a number of problems for the paediatric anesthesiologist. The application of the stereotactic frame and subsequent imaging of the brain with computerized tomography (CT) require general anaesthesia. Planning may take several hours and treatment requires a further period of immobility and patient cooperation. Dexmedetomidine is a potent α 2 adrenergic agonist with demonstrated sedative, analgesic and anxiolytic effects [1] [2] [3] . These properties would suggest that it could be a suitable agent for this lengthy procedure, although little has been published on the use of dexmedetomidine in children 4 .
CASE HISTORY
A six-year-old boy presented to our institution for treatment of a right thalamic AVM. As the location of the lesion and its size made it unsuitable for surgical resection or embolization, stereotactic radiosurgery in two stages was selected as the optimal treatment option. Following appropriate preoperative assessment, preparation and application of standard moni-toring (electrocardiography, pulse oximetry, capnography and non-invasive blood pressure), anesthesia was induced and maintained with sevoflurane with nitrous oxide and oxygen. An intravenous cannula was inserted, a laryngeal mask airway (LMA) size 2.5 was placed and fentanyl 1.5 µg/kg was administered intravenously. Following infiltration of the skin and periosteum with 0.5% bupivacaine, the stereotactic frame was fixed with appropriate pins to the patient's head and CT scanning commenced. A dexmedetomidine infusion was started at 0.3 µg/kg/h. Upon completion of imaging, sevoflurane and nitrous oxide were discontinued and the patient was transferred to a recovery area where monitoring was continued and a bispectral index monitor was attached (BIS value on arrival=46). He quickly regained consciousness (BIS=92), the LMA was removed, the dexmedetomodine infusion was increased 0.7 µg/kg/h and fentanyl 1 µg/kg was administered. From this point on, both BIS and Ramsay Sedation (RS) scores were used to guide sedation ( Figure 1 ) 5 . Initially the patient was comfortably sedated with BIS values 70-80 (RS=6), but with minimal stimulation rapidly roused (BIS 92-94, RS=1) and attempted to remove the frame. A low-dose propofol infusion was commenced (20 µg/kg/min) and the patient remained sedated (BIS 70-80, RS=3-4), spontaneously breathing, easily rousable and hemodynamically stable for the following six hours. Sedation was continued while he was transferred to the treatment area, positioned and treated. The propofol infusion was discontinued midway through treatment and dexmedetomidine discontinued at the end of treatment. He returned to the recovery area and awoke quickly but remained drowsy for the following 90 minutes whereupon he was transferred to the neurology ward. He was discharged the following day with no adverse consequences and no memory of the previous day's events.
Four months later, the same patient presented for treatment of the deeper portion of his AVM. The procedure was as before with regard to anaesthesia, treatment and planning. On this occasion, a loading dose of dexmedetomidine (1 µg/kg over 20 minutes) was administered prior to discontinuation of anaesthesia and a higher infusion rate was used (0.5 µg/ kg/h to 1.4 µg/kg/h). Despite this higher rate, it was again necessary, after 200 minutes, to commence a propofol infusion (20 µg/kg/h) to achieve adequate sedation. Although haemodynamically stable and breathing, upper airway obstruction occurred requiring jaw support. Therefore the dexmedetomidine infusion was discontinued and, following induction of anaesthesia with propofol 2 mg/kg and rocuronium 0.6 mg/kg, the patient's trachea was intubated and mechanical ventilation begun. The remainder of treatment and planning took a further two hours and was uneventful. The patient woke up promptly on discontinuation of anaesthesia and was extubated. He was discharged home the following day with no adverse sequelae.
DISCUSSION
Radiosurgery aims at complete obliteration of the lesion by a concentrated beam of charged particles, which gradually leads to vascular sclerosis. The smaller the lesion the better the results. The process occurs in three stages: The lesion is imaged following application of a stereotactic frame, using these images a treatment plan is developed (duration is up to three hours) and finally the patient is treated (approximately 30 minutes). From its initial application to the end of treatment, the stereotactic frame must remain on the patient in the original position. Radiosurgery in the paediatric population presents a number of difficult challenges to the anaesthesiologist: The procedure is prolonged, often taking up to eight hours, the stereotactic frame must be applied and remain exactly in the same position throughout and the procedures often take place in a number of different locations. In younger children, the frame must be applied following induction of general anaesthesia and the child must remain either anaesthetized or sedated for the rest of the day in order to keep the frame in position. In previous reports the patients have been anaesthetized, intubated for the initial imaging, the wait period and the subsequent treatment 6, 7 .
Dexmedetomidine is a relatively new agent which has been approved for use as a sedative in adults in the intensive care setting 8 . Experience with its use in children is limited. Dexmedetomidine is a highly selective agonist of α 2 adrenoceptors, with an affinity eight times that of clonidine. The stimulation of presynaptic α 2 adrenoceptors in the central nervous system results in inhibition of sympathetic activity, reduction in blood pressure and heart rate, and sedation. Similar agonism at the level of the spinal cord produces analgesia 9 . There is more experience of the anaesthetic sparing effects of clonidine in children. Clonidine has been shown to lead to a reduction in halothane requirements in paediatric patients 10 .
We proposed that dexmedetomidine would be a suitable agent for sedation during planning and treatment of this patient. Due to the age of the patient, general anesthesia was necessary for application of the stereotactic frame and initial CT scanning. We followed the recommended dosage schedule as outlined by the manufacturer, whose maximum recommended dose is 0.7 µg/kg/hour 8 . We found that this infusion rate was insufficient for reliable sedation in our patient, but the addition of propofol at a low rate (20 µg/kg/min) conferred acceptable levels of sedation and comfort initially. After the first treatment, it was felt that the omission of a loading dose necessitated the use of supplementary propofol. Therefore when the patient returned for his second procedure, we administered an appropriate loading dose and increased the infusion rate to 1.4 µg/kg/h. This high dose ensured adequate sedation but sudden unpredictable wake-up occurred necessitating the addition of propofol.
The use of dexmedetomidine for sedation of an 11year-old boy having upper gastrointestinal endoscopy Ramsay Sedation Score
RS1
Patient anxious , restless or both RS2
Patient co-operative, orientated or quiet RS3
Patient responds to command only RS4
Patient responds briskly to light glabellar tap or loud stimulus RS5
Patient responds sluggishly to a light glabellar tap or loud auditory stimulus RS6
Patient does not respond to a light glabellar tap or loud auditory stimulus FIGURE 1: Ramsay Sedation Score.
has been described 4 . In order to achieve sedation, it was necessary to administer two boluses of dexmedetomidine (0.6 µg/kg each) followed by a continuous infusion (0.5 µg/kg/h). Despite initial sedation, rapid arousal followed introduction of the endoscope, necessitating supplementation with midazolam and ketamine. Dexmedetomidine has been successfully used as the primary sedating agent for awake craniotomy in two 12-year-old children. Following extensive preoperative neuropsychological counselling, both received general anaesthesia followed by dexmedetomidine sedation for the awake portion of the procedure. The first patient also had a concurrent remifentanil infusion (0.1 µg/kg/min) throughout the procedure, while the second patient required supplemental fentanyl during the awake portion of the procedure. The authors concluded that dexmedetomidine was successful, but suggested that it may provide insufficient pain relief and supplemental analgesia may be necessary 11 . We found that in order to achieve adequate sedation in our patient, it was necessary to supplement dexmedetomidine with a propofol infusion, despite using higher than recommended infusion rates. The most likely reason for the sudden arousal of our patient was stimulation from the pins of the stereotactic frame despite local infiltration. This would suggest that, despite having some analgesic properties, dexmedetomidine may need supplementation with analgesic agents for potentially painful procedures. Ard and co-workers suggested that a low-dose remifentanil infusion might be a suitable supplementary analgesic for awake craniotomies 11 . The use of an easily titratable analgesic such as remifentanil in conjunction with dexmedetomidine may confer greater success for sedation in paediatric patients.
A randomized controlled trial of dexmedetomidine sedation (two infusion doses versus midazolam infusion) in children receiving mechanical ventilation in an intensive care unit has been published. In this small study, where morphine bolus doses were part of the protocol, the higher dose of dexmedetomidine was of similar efficacy to the midazolam infusion. There are no published controlled trials of dexmedetomidine use for procedural sedation in children 12 .
In conclusion, we have reported our use of dexmedetomidine as an alternative to general anaesthesia for stereotactic radiosurgery in a paediatric patient. Despite adhering to recommended adult loading dose guidelines and using higher maintenance infusion rates, we found that dexmedetomidine, as a sole agent, proved unreliable in providing adequate sedation in our patient on two occasions.
